Skip to content
Menu

Head-to-head comparison

Queen RX vs Sunlight

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Ranked #135
Queen RX

Queen RX offers compounded GLP-1 treatment (semaglutide, tirzepatide, liraglutide) at $299/quarter (~$100/mo).

$100/mo (quarterly prepay) sema · Verified July 2026

Marked down on: No LegitScript or PCAB accreditation

vs
Ranked #19Desk pick
Sunlight

The lowest published entry prices here — semaglutide from $88/mo, tirzepatide from $157/mo, flat monthly with no membership and no prepay — from a LegitScript-certified desk that names two NPI-verified physicians and six dispensing pharmacies.

From $88/mo sema · From $157/mo tirz · Verified August 2026

Marked down on: Injectable only for GLP-1 — no oral tablet route on semaglutide or tirzepatide, despite a generic "Injections and oral options available" line in one landing page's hero that matches nothing else on the site

Sunlight takes this head-to-head with the higher Desk Score, 85/100 (B) against 74/100 (C) for Queen RX. Queen RX still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

Queen RX

74/100

C

Overall

Sunlight

85/100

B

Price transparency

76
86

State access

78
96

Molecule range

71
76

Onboarding speed

74
84

Support responsiveness

76
78

Licensing & trust

63
86

The spec sheet

FieldQueen RXSunlight
Semaglutide$100/moquarterly prepay$100/mo (quarterly plan, compounded)From $88/moStarts at $88/mo (compounded injection, flat monthly with no membership on top; a fresh 4-week supply each shipment, and the FAQ says the rate includes the prescription, unlimited telehealth visits and free shipping)
TirzepatideNot listed on Queen RX's site (checked July 2026)From $157/moStarts at $157/mo (compounded injection, flat monthly with no membership on top; a fresh 4-week supply each shipment, prescription and unlimited telehealth visits included)
Coverage45 statesAll 50 states (varies by provider licensure; the NAD+ and sermorelin lines name Mississippi as their one exception)
Brand-nameCompounded onlyCompounded only
Oral optionInjectable onlyInjectable only
Best forBudget-conscious patients seeking low-cost compounded GLP-1.Patients who want the lowest published entry price in the ranking and are comfortable with an injection-only compounded program, and don't need an oral or brand-name route.
Desk Score74/100C85/100B

The verdict

Desk pick — Sunlight

Sunlight takes this head-to-head with the higher Desk Score, 85/100 (B) against 74/100 (C) for Queen RX. Queen RX still holds its ground where its strengths line up with yours.

Choose Queen RX if…

Budget-conscious patients seeking low-cost compounded GLP-1.

$100/mo (quarterly prepay) sema · 45 states

Choose Sunlight if…

Patients who want the lowest published entry price in the ranking and are comfortable with an injection-only compounded program, and don't need an oral or brand-name route.

From $88/mo sema · From $157/mo tirz · All 50 states (varies by provider licensure; the NAD+ and sermorelin lines name Mississippi as their one exception)

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Queen RX · Sunlight.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.